Bicyclic Caspase Inhibitor Structure for Selective Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for caspase-related diseases lack effective caspase inhibitors that can selectively target caspase receptors without causing inflammation, as existing therapies may lead to tissue damage during cell death processes.
Innovation Solution
Development of a compound represented by formula (I) and its pharmaceutically acceptable salts, which are designed to inhibit caspase activity, thereby preventing or treating caspase receptor-related diseases by administering a therapeutically effective amount of the compound or its pharmaceutical composition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing caspase inhibitors are used to treat caspase-related diseases, then caspase activity is inhibited, but tissue damage and inflammation occur during cell death processes
Solution Approach 1:
The patent modifies the chemical structure parameters of caspase inhibitors by introducing specific bicyclic frameworks with varied substituents (halogens, hydroxyl groups, amino groups, alkyl groups) to optimize the balance between caspase inhibition potency and reduction of harmful effects on tissues
Solution Approach 2:
The patent introduces specific substituent patterns at different positions of the bicyclic core structure (ring A and ring B with specific R groups) to create localized functional regions that enhance selective binding to caspase receptors while minimizing off-target effects that cause inflammation
2Object-affected harmful factors
If caspase activity is inhibited to prevent necrotic cell death, then tissue damage is reduced, but selective targeting of caspase receptors without affecting other cellular processes becomes challenging
Solution Approach 1:
The patent divides the caspase inhibitor molecule into distinct functional segments: a bicyclic core structure providing structural rigidity and specific binding geometry, and variable substituent groups (R, R1) that can be independently optimized for selective interaction with caspase receptor pockets, enabling precise targeting
Solution Approach 2:
The patent creates composite molecular structures combining the bicyclic framework with diverse substituent chemistries (halogens, hydroxyl, amino, alkyl groups) to achieve multiple functional properties simultaneously: high binding affinity for caspase receptors, selective specificity, and reduced off-target effects
Data Source
AI summary
A compound represented by formula (I), a pharmaceutically acceptable salt or tautomer thereof, and an application of the compound as a caspase inhibitor.